Literature DB >> 16981676

Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants.

Mireille Dumoulin1, Janet R Kumita, Christopher M Dobson.   

Abstract

Studies of lysozyme have played a major role over several decades in defining the general principles underlying protein structure, folding, and stability. Following the discovery some 10 years ago that two mutational variants of lysozyme are associated with systemic amyloidosis, these studies have been extended to investigate the mechanism of amyloid fibril formation. This Account describes our present knowledge of lysozyme folding and misfolding, and how the latter can give rise to amyloid disease. It also discusses the significance of these studies for our general understanding of normal and aberrant protein folding in the context of human health and disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981676     DOI: 10.1021/ar050070g

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  26 in total

1.  Kinetics of surfactant-induced aggregation of lysozyme studied by fluorescence spectroscopy.

Authors:  Neha Jain; Mily Bhattacharya; Samrat Mukhopadhyay
Journal:  J Fluoresc       Date:  2010-10-16       Impact factor: 2.217

2.  Shear-induced unfolding of lysozyme monitored in situ.

Authors:  Lorna Ashton; Jonathan Dusting; Eboshogwe Imomoh; Stavroula Balabani; Ewan W Blanch
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

Review 3.  Amyloid formation by globular proteins under native conditions.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Nat Chem Biol       Date:  2009-01       Impact factor: 15.040

4.  Hen lysozyme amyloid fibrils induce aggregation of erythrocytes and lipid vesicles.

Authors:  Nitin Chaudhary; Ramakrishnan Nagaraj
Journal:  Mol Cell Biochem       Date:  2009-03-26       Impact factor: 3.396

5.  Protein fibrillation lag times during kinetic inhibition.

Authors:  Rodrigo S Pagano; Máximo López Medus; Gabriela E Gómez; Paula M Couto; María S Labanda; Lucas Landolfo; Cecilia D'Alessio; Julio J Caramelo
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

6.  Amyloid formation by human carboxypeptidase D transthyretin-like domain under physiological conditions.

Authors:  Javier Garcia-Pardo; Ricardo Graña-Montes; Marc Fernandez-Mendez; Angels Ruyra; Nerea Roher; Francesc X Aviles; Julia Lorenzo; Salvador Ventura
Journal:  J Biol Chem       Date:  2014-10-07       Impact factor: 5.157

7.  Local cooperativity in an amyloidogenic state of human lysozyme observed at atomic resolution.

Authors:  Anne Dhulesia; Nunilo Cremades; Janet R Kumita; Shang-Te Danny Hsu; Maria F Mossuto; Mireille Dumoulin; Daniel Nietlispach; Mikael Akke; Xavier Salvatella; Christopher M Dobson
Journal:  J Am Chem Soc       Date:  2010-11-10       Impact factor: 15.419

8.  Activation of innate immunity by lysozyme fibrils is critically dependent on cross-β sheet structure.

Authors:  Adelin Gustot; Vincent Raussens; Morgane Dehousse; Mireille Dumoulin; Clare E Bryant; Jean-Marie Ruysschaert; Caroline Lonez
Journal:  Cell Mol Life Sci       Date:  2013-01-19       Impact factor: 9.261

9.  Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases.

Authors:  Angel L Pey; Francois Stricher; Luis Serrano; Aurora Martinez
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

10.  A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.

Authors:  Erwin De Genst; Pak-Ho Chan; Els Pardon; Shang-Te D Hsu; Janet R Kumita; John Christodoulou; Linda Menzer; Dimitri Y Chirgadze; Carol V Robinson; Serge Muyldermans; André Matagne; Lode Wyns; Christopher M Dobson; Mireille Dumoulin
Journal:  J Phys Chem B       Date:  2013-09-24       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.